NCT00029614已完成2 期
Psychopharmacology of Adolescents With AUD and ADHD
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- decrease in ADHD symptoms
研究概览
简要总结
The purpose of this study is to compare the effectiveness and safety of atomoxetine in the treatment of adolescents with coexisting alcohol or substance use disorders and Attention Deficit Hyperactivity Disorder (ADHD).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 13 Years 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adolescents, ages 13-18
- •Meets criteria for alcohol and/or substance use disorder and attention deficit hyperactivity disorder.
排除标准
- •Adolescents who are pregnant.
- •Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk.
- •History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders.
- •Currently on other psychotropic medications from which discontinuation would present a significant risk.
- •A current episode of major depressive disorder or a diagnosis of bipolar disorder.
- •Diagnosis of dependence for any substance other than marijuana.
- •Adolescents with a full-scale IQ below 80.
结局指标
主要结局
decrease in ADHD symptoms
decrease in the quantity and frequency of alcohol and other substance use
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Atomoxetine for Treating Attention Deficit Hyperactivity Disorder in Young ChildrenAttention Deficit Disorder With HyperactivityNCT00254462University of Nebraska93
已完成
不适用
Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment FacilityAttention Deficit Hyperactivity DisorderNCT00953862NYU Langone Health18
已完成
4 期
Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum DisorderAutistic DisorderAttention Deficit Disorder With HyperactivityNCT00380692Eli Lilly and Company97
已完成
3 期
Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/AdolescentsAttention Deficit Hyperactivity DisorderNCT00191659Eli Lilly and Company200
已完成
4 期
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional OutcomesAttention Deficit Hyperactivity DisorderNCT00510276Eli Lilly and Company445